Yoshiya Tanaka Selected Research

Yoshiya Tanaka Research Topics

Disease

277	Rheumatoid Arthritis 11/2022 - 07/2001
66	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2022 - 10/2003
45	Type 2 Diabetes Mellitus (MODY) 04/2022 - 06/2005
41	Infections 07/2022 - 02/2004
36	Osteoporosis 04/2022 - 06/2003
33	Neoplasms (Cancer) 04/2022 - 01/2002
32	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 02/2002
26	Inflammation (Inflammations) 05/2022 - 07/2001
22	Herpes Zoster 07/2022 - 01/2016
19	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 02/2006
16	Immunoglobulin G4-Related Disease 01/2022 - 02/2012
15	Pathologic Processes 01/2022 - 03/2002
14	Arthritis (Polyarthritis) 10/2022 - 02/2004
14	Necrosis 05/2022 - 08/2012
14	Rheumatic Diseases (Rheumatism) 09/2020 - 01/2007
13	Bone Resorption 04/2022 - 08/2002
12	Hyperglycemia 01/2020 - 06/2005
11	Psoriatic Arthritis 07/2022 - 07/2016
10	Pain (Aches) 07/2022 - 03/2013
9	Bone Fractures (Bone Fracture) 11/2019 - 06/2003
8	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 07/2015
8	Hypercalcemia (Milk Alkali Syndrome) 10/2020 - 01/2004
7	Dermatomyositis (Dermatopolymyositis) 11/2022 - 01/2008
7	Fibrosis (Cirrhosis) 01/2022 - 10/2009
7	Drug-Related Side Effects and Adverse Reactions 05/2020 - 01/2007
7	Vascular Calcification 01/2019 - 08/2006
7	Diabetes Mellitus 01/2017 - 06/2006
7	Atherosclerosis 05/2016 - 05/2003
6	Lupus Nephritis 10/2022 - 01/2016
6	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2004
6	Vasculitis (Vasculitides) 01/2022 - 12/2003
6	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2020 - 06/2002
6	Insulin Resistance 01/2019 - 01/2006
6	Graves Disease (Basedow Disease) 01/2017 - 01/2014
5	Fatigue 07/2022 - 11/2017
5	Hypertension (High Blood Pressure) 01/2022 - 07/2012
5	Lung Diseases (Lung Disease) 01/2022 - 11/2012
5	Fever (Fevers) 01/2022 - 11/2005

Drug/Important Bio-Agent (IBA)

68	Methotrexate (Mexate)FDA LinkGeneric 11/2022 - 12/2002
50	Biological ProductsIBA 04/2022 - 09/2005
42	GlucocorticoidsIBA 04/2022 - 06/2003
41	Antirheumatic Agents (DMARD)IBA 01/2022 - 02/2004
39	Janus Kinase InhibitorsIBA 07/2022 - 01/2012
37	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2006
31	Adalimumab (Humira)FDA Link 02/2022 - 06/2012
30	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2022 - 06/2005
29	CytokinesIBA 01/2022 - 07/2001
26	baricitinibIBA 05/2022 - 03/2016
26	tofacitinibIBA 06/2021 - 08/2011
25	tocilizumab (atlizumab)FDA Link 01/2021 - 04/2011
23	Monoclonal AntibodiesIBA 03/2022 - 01/2008
22	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2005
19	Diphosphonates (Bisphosphonates)IBA 05/2021 - 11/2002
18	Etanercept (Enbrel)FDA Link 03/2020 - 01/2009
17	Abatacept (Orencia)FDA Link 04/2022 - 01/2014
17	Immunoglobulin G (IgG)IBA 03/2022 - 02/2012
17	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 07/2011
17	AutoantibodiesIBA 12/2021 - 12/2002
17	Pharmaceutical PreparationsIBA 03/2021 - 06/2005
16	Interleukin-6 (Interleukin 6)IBA 05/2022 - 11/2007
16	Infliximab (Remicade)FDA Link 11/2021 - 01/2007
14	peficitinibIBA 07/2022 - 06/2016
14	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2009
14	Janus KinasesIBA 05/2022 - 01/2014
13	Rituximab (Mabthera)FDA Link 02/2022 - 01/2007
13	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2013
12	Prednisolone (Predate)FDA LinkGeneric 10/2022 - 02/2004
12	Insulin (Novolin)FDA Link 04/2022 - 06/2005
12	Denosumab FDA Link 11/2021 - 05/2010
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 10/2003
11	Certolizumab Pegol FDA Link 01/2021 - 07/2014
11	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2018 - 12/2004
10	AntibodiesIBA 11/2022 - 06/2011
9	SteroidsIBA 10/2022 - 10/2003
9	Hemoglobins (Hemoglobin)IBA 04/2022 - 03/2005
9	upadacitinibIBA 02/2022 - 01/2019
8	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 10/2003
8	belimumabIBA 01/2022 - 01/2018
7	GLPG0634IBA 04/2022 - 01/2021
7	InterleukinsIBA 03/2022 - 12/2014
7	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 12/2012
7	InterferonsIBA 01/2022 - 06/2012
7	AntigensIBA 01/2021 - 08/2002
7	Proteins (Proteins, Gene)FDA Link 12/2020 - 06/2005
7	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2020 - 04/2013
6	sarilumabIBA 07/2022 - 09/2014
6	LigandsIBA 05/2022 - 04/2013
6	anifrolumabIBA 02/2022 - 01/2020
6	Vitamin D FDA LinkGeneric 02/2022 - 12/2012
6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 01/2020
6	sirukumabIBA 01/2021 - 09/2014
6	alfacalcidolIBA 07/2020 - 01/2004
6	golimumab FDA Link 09/2018 - 06/2012
6	oxidized low density lipoproteinIBA 03/2018 - 02/2002
5	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2018
5	CreatinineIBA 04/2021 - 09/2002

Therapy/Procedure

146	Therapeutics 11/2022 - 09/2002
8	Glycemic Control 02/2019 - 06/2006
7	Remission Induction 01/2022 - 02/2004
6	Precision Medicine 01/2022 - 07/2016